Skip to main content

and
  1. Article

    Open Access

    Androgen receptor status is highly conserved during tumor progression of breast cancer

    With the advent of new and more efficient anti-androgen drugs targeting androgen receptor (AR) in breast cancer (BC) is becoming an increasingly important area of investigation. This would potentially be most ...

    André Grogg, Mafalda Trippel, Katrin Pfaltz, Claudia Lädrach in BMC Cancer (2015)

  2. Article

    Open Access

    Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+tumor infiltrating lymphocytes in ductal and lobular breast cancers

    Clinical relevance of tumor infiltrating lymphocytes (TILs) in breast cancer is controversial. Here, we used a tumor microarray including a large series of ductal and lobular breast cancers with long term foll...

    Raoul Droeser, Inti Zlobec, Ergin Kilic, Uwe Güth, Michael Heberer in BMC Cancer (2012)